AmerisourceBergen Corp (ABC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

AmerisourceBergen Corp (ABC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile


  • Products Id :- GDPH27286D
  • |
  • Pages: 80
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

AmerisourceBergen Corp (AmerisourceBergen) is a pharmaceutical sourcing and distribution services company that provides pharmaceutical products, business solutions and value-driving services that improve access to care. The company distributes a broad offering of brand-name, specialty brand-name, over-the-counter (OTC) healthcare products, generic pharmaceuticals, equipment, home healthcare supplies, outsourced compounded sterile preparations and related services. It serves numerous healthcare providers in the US and selected global markets, comprising independent and chain retail pharmacies, acute care hospitals and health systems, medical clinics, mail order pharmacies, medical and dialysis clinics, physician practices, long-term care and alternate site pharmacies, veterinarians and other customers. AmerisourceBergen is headquartered in Chesterbrook, Pennsylvania, the US.

AmerisourceBergen Corp (ABC)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

AmerisourceBergen Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

AmerisourceBergen Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

AmerisourceBergen Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

AmerisourceBergen Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

AmerisourceBergen Corp, Medical Devices Deals, 2012 to YTD 2018 10

AmerisourceBergen Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

AmerisourceBergen Corp, Pharmaceuticals & Healthcare, Deal Details 12

Partnerships 12

AmerisourceBergen And Profarma Distribuidora de Produtos Farma Forms Joint Venture 12

Equity Offering 13

AmerisourceBergen Raises USD1.17 Billion in Private Placement of Shares up on Exercise of Warrants 13

Debt Offering 14

AmerisourceBergen Raises USD500 Million in Public Offering of 4.3% Senior Notes Due 2047 14

AmerisourceBergen Raises USD750 Million in Public Offering of 3.45% Senior Notes Due 2027 16

AmerisourceBergen Raises USD500 Million in Public Offering of 3.4% Notes 18

AmerisourceBergen Raises USD600 Million in Public Offering of 1.15% Notes 20

Acquisition 22

Walgreens Boots Alliance May Acquire Remaining 74% Stake in AmerisourceBergen 22

AmerisourceBergen Completes Acquisition of 19.9% Stake in Profarma Distribuidora de Produtos Farma for USD61.7 Million 23

H. D. Smith Completes Acquisition Of Remaining 49% Interest In Triplefin 24

Kohl & Frisch Completes Acquisition Of AmerisourceBergen Canada For Up To USD 100 Million 26

Walgreen And Alliance Boots Receive Regulatory Clearance To Acquire Up To 25% Stake In AmerisourceBergen 27

Triplefin Acquires Minority Stake In Specialty Pharmacy Nursing Network 29

H. D. Smith Wholesale Drug Completes Acquisition Of Valley Wholesale Drug 30

AmerisourceBergen Corp-Key Competitors 31

AmerisourceBergen Corp-Key Employees 32

AmerisourceBergen Corp-Locations And Subsidiaries 34

Head Office 34

Other Locations & Subsidiaries 34

Recent Developments 36

Strategy And Business Planning 36

Aug 29, 2018: ICS opens new third-party logistics pharmaceutical distribution center 36

Jun 19, 2017: AmerisourceBergen Structures Operating Model and Executive Leadership Team to Offer a More Cohesive and Unified Customer Experience, Enhance Growth and Drive Long-Term Value 37

Financial Announcements 38

Aug 02, 2018: AmerisourceBergen posts fiscal 2018 Q3 results 38

May 02, 2018: AmerisourceBergen Reports Fiscal 2018 Second Quarter Results 39

Feb 06, 2018: AmerisourceBergen Reports Fiscal 2018 First Quarter Results 42

Nov 02, 2017: AmerisourceBergen Reports Fiscal 2017 Fourth Quarter and Year End Results 45

Aug 03, 2017: AmerisourceBergen Reports Third Quarter Fiscal Year 2017 Results 50

May 04, 2017: AmerisourceBergen Reports Second Quarter Fiscal Year 2017 Results 53

Jan 31, 2017: AmerisourceBergen Reports First Quarter Fiscal Year 2017 Results 56

Corporate Communications 59

Sep 10, 2018: AmerisourceBergen Announces Financial Leadership Change 59

May 15, 2018: Lash Group Launches Artificial Intelligence-Powered Electronic Benefit Verification Solution May 2018 60

Oct 04, 2017: AmerisourceBergen, Blue Cross Blue Shield Association, Pfizer and Prime Therapeutics Join Walgreens to Combat Prescription Drug Abuse by Expanding Safe Medication Disposal Program 61

Sep 19, 2017: AmerisourceBergen and the AmerisourceBergen Foundation Commit More Than USD 100,000 to Support Victims of Hurricanes Harvey and Irma 63

Legal and Regulatory 64

Oct 01, 2018: AmerisourceBergen to Pay USD 625 million to settle civil fraud allegations resulting from its repackaging and sale of adulterated drugs and unapproved new drugs, double billing and providing kickbacks 64

Aug 15, 2017: City of Birmingham and Legal Counsel Baron & Budd, Greene Ketchum, Levin Papantonio File Suit Against Pharmaceutical Distributors for Role in Creating Opioid Crisis 67

Jul 10, 2017: AmerisourceBergen Recognized as Best In Class for Specialty Distribution Quality 68

Jun 23, 2017: CPPA Accredits US Bioservices, a part of AmerisourceBergen, for Specialty Pharmacy 69

Government and Public Interest 70

Mar 09, 2018: The Moyer Foundation Receives Grant from the AmerisourceBergen Foundation to Launch New Community Program for Children Living with Addiction in their Families 70

Feb 15, 2018: AmerisourceBergen Comments on DEA's Creation of Transparency Resource to Help Distributors Combat Opioid Abuse 71

Nov 13, 2017: AmerisourceBergen Urges Policymakers to Support Regulator and Industry Data Transparency to More Effectively Combat Opioid Abuse 72

Product News 73

Feb 13, 2017: IntrinsiQ Specialty Solutions and ION Solutions Provide Independent Oncology, Urology Practices Improved Access to Clinical Trials with the Launch of AdvanceIQ Network 73

Other Significant Developments 74

May 30, 2018: US Bioservices Collaborates with MedImpact Direct to Support Hemophilia Patients 74

Dec 14, 2017: AmerisourceBergen Foundation Launches Municipal Support Program to Help Combat Opioid Abuse 75

Oct 04, 2017: Lash Group Launches Fusion, a New Technology Ecosystem to Power the Future of Patient Support Services 76

Aug 14, 2017: AmerisourceBergen Helps Innovators Navigate Commercialization for Cell and Gene Therapies 77

Jul 21, 2017: Good Neighbor Pharmacy Equips Independent Pharmacists to be Vital Source of Care in Today's Healthcare Environment 78

Mar 28, 2017: AmerisourceBergen enhances specialty medication management, storage solution Cubixx 79

Appendix 80

Methodology 80

About GlobalData 80

Contact Us 80

Disclaimer 80

List of Figures

AmerisourceBergen Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

AmerisourceBergen Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

AmerisourceBergen Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

AmerisourceBergen Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

AmerisourceBergen Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

AmerisourceBergen Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

AmerisourceBergen Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

AmerisourceBergen Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

AmerisourceBergen Corp, Medical Devices Deals, 2012 to YTD 2018 10

List of Tables

AmerisourceBergen Corp, Pharmaceuticals & Healthcare, Key Facts, 2017 2

AmerisourceBergen Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

AmerisourceBergen Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

AmerisourceBergen Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

AmerisourceBergen Corp, Deals By Therapy Area, 2012 to YTD 2018 9

AmerisourceBergen Corp, Medical Devices Deals, 2012 to YTD 2018 10

AmerisourceBergen Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

AmerisourceBergen And Profarma Distribuidora de Produtos Farma Forms Joint Venture 12

AmerisourceBergen Raises USD1.17 Billion in Private Placement of Shares up on Exercise of Warrants 13

AmerisourceBergen Raises USD500 Million in Public Offering of 4.3% Senior Notes Due 2047 14

AmerisourceBergen Raises USD750 Million in Public Offering of 3.45% Senior Notes Due 2027 16

AmerisourceBergen Raises USD500 Million in Public Offering of 3.4% Notes 18

AmerisourceBergen Raises USD600 Million in Public Offering of 1.15% Notes 20

Walgreens Boots Alliance May Acquire Remaining 74% Stake in AmerisourceBergen 22

AmerisourceBergen Completes Acquisition of 19.9% Stake in Profarma Distribuidora de Produtos Farma for USD61.7 Million 23

H. D. Smith Completes Acquisition Of Remaining 49% Interest In Triplefin 24

Kohl & Frisch Completes Acquisition Of AmerisourceBergen Canada For Up To USD 100 Million 26

Walgreen And Alliance Boots Receive Regulatory Clearance To Acquire Up To 25% Stake In AmerisourceBergen 27

Triplefin Acquires Minority Stake In Specialty Pharmacy Nursing Network 29

H. D. Smith Wholesale Drug Completes Acquisition Of Valley Wholesale Drug 30

AmerisourceBergen Corp, Key Competitors 31

AmerisourceBergen Corp, Key Employees 32

AmerisourceBergen Corp, Subsidiaries 34

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

AmerisourceBergen Corp, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license
Single User License
USD 250 INR 17805
Site License
USD 500 INR 35610
Corporate User License
USD 750 INR 53415

NEWSLETTER BY CATEGORY




Testimonials

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com